Fichero a descargar de la publicación mostrada - Sociedad ...

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 62______________________________________________________________________________369. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheterinfections by topical povidone-iodine. Kidney Int 1991; 40:934-8.370. Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using centralvenous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085-92.371. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulasenegativestaphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. JHosp Infect 1995; 31:189-93.372. Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int 1997; 17:410-2.373. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with theuse of an intravascular needleless valve. Clin Infect Dis 2007; 44:1408-14.374. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. A prospective clinical study to investigate themicrobial contamination of a needleless connector. J Hosp Infect 2000; 45:165-8.375. Cookson ST, Ihrig M, O'Mara EM, et al. Increased bloodstream infection rates in surgical patients associatedwith variation from recommended use and care following implementation of a needleless device. Infect ControlHosp Epidemiol 1998; 19:23-7.376. Johnson BH, Rypins EB. Single-lumen vs double-lumen catheters for total parenteral nutrition. A randomized,prospective trial. Arch Surg 1990; 125:990-2.377. McCarthy MC, Shives JK, Robison RJ, Broadie TA. Prospective evaluation of single and triple lumencatheters in total parenteral nutrition. JPEN J Parenter Enteral Nutr 1987; 11:259-62.378. Ma TY, Yoshinaka R, Banaag A, Johnson B, Davis S, Berman SM. Total parenteral nutrition via multilumencatheters does not increase the risk of catheter-related sepsis: a randomized, prospective study. Clin Infect Dis1998; 27:500-3.379. López-Briz E, Ruiz-García V. [Effectiveness of heparin versus NaCl 0.9% in central venous catheter flushing.A systematic review]. Farm Hosp 2005; 29:258-64.380. Rabe C, Gramann T, Sons X, et al. Keeping central venous lines open: a prospective comparison of heparin,vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 2002; 28:1172-6.381. Smith S, Dawson S, Hennessey R, Andrew M. Maintenance of the patency of indwelling central venouscatheters: is heparin necessary? Am J Pediatr Hematol Oncol 1991; 13:141-3.382. Rice L. Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you andyour patient). Arch Intern Med 2004; 164:1961-4.383. Kethireddy S, Safdar N. Urokinase lock or flush solution for prevention of bloodstream infections associatedwith central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials. J Vasc Access2008; 9:51-7.384. Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G. Prevention of intravascular catheterrelatedinfection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.Intensive Care Med 2004; 30:837-43.385. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated withchlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. AnnIntern Med 2005; 143:570-80.386. Ostendorf T, Meinhold A, Harter C, et al. Chlorhexidine and silver-sulfadiazine coated central venouscatheters in haematological patients-a double-blind, randomised, prospective, controlled trial. Support CareCancer 2005; 13:993-1000.